Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Randomized Controlled Trial of Efficacy and Safety of Renal Denervation for Resistant Hypertension

NCT02900729 is registered in ClinicalTrials.gov with Shanghai WiseGain Medical Devices Co., Ltd. as lead sponsor.

NCT NCT02900729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02900729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Randomized Controlled Trial of Efficacy and Safety of Renal Denervation for Resistant Hypertension
Lead sponsor
Shanghai WiseGain Medical Devices Co., Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2016
Completion date
February 28, 2018
Enrollment
254 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension